Deregulation to revitalize OTC market

OTC drugmakers is breathing a sigh of relief as the Korea Food and Drug Administration is actively moving ahead to deregulate validation rules governing OTC products with standardized dosage and formulation method.

According to the KFDA, the mandatory submission of validation documents for new and existing OTC items will be waivered.

These items, which account for 20 percent of total OTC ...